Physician profile
Hailey J Artz
NPI 1467958603
$588.05
in general payments reported to CMS, 2019-2025
16 companies · $290 in 2025
The $290 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $39.15 · 2022: $83.87 · 2024: $175 · 2025: $290.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $465.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $465.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $154.48 | 2021-2025 | |
| Novo Nordisk INC | $86.80 | 2024-2025 | Wegovy, Rybelsus, Ozempic |
| Astrazeneca Pharmaceuticals LP | $49.68 | 2025 | Airsupra, Farxiga |
| Pfizer INC. | $47.72 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $37.67 | 2024 | |
| Dexcom, INC. | $34.22 | 2025 | Dexcom G6 Transmitter |
| Astellas Pharma US INC | $34.03 | 2024 | Veozah |
| Abbott Laboratories | $23.57 | 2025 | Freestyle Libre 3 |
| Exact Sciences Corporation | $20.37 | 2025 | Cologuard Collection Kit |
| Otsuka America Pharmaceutical, INC. | $18.66 | 2024 | Rexulti |
| Merck Sharp & Dohme LLC | $15.54 | 2024 | M-M-R II, Rotateq, Capvaxive |
| Inspire Medical Systems, INC. | $14.28 | 2025 | Inspire |
| Lilly USA, LLC | $13.89 | 2025 | Mounjaro, Zepbound |
| Amgen INC. | $13.83 | 2024 | Repatha, Otezla |
| Corcept Therapeutics | $13.80 | 2025 | Korlym |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $9.51 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hailey Artz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.